- Home
- BWMX vs TERN Comparison
BWMX vs TERN Comparison
Compare BWMX & TERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BWMX | TERN |
|---|---|---|
| Founded | 1995 | 2017 |
| Country | Mexico | United States |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 495.6M | 3.8B |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | BWMX | TERN |
|---|---|---|
| Price | $14.24 | $44.85 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 10 |
| Target Price | $22.50 | ★ $48.60 |
| AVG Volume (30 Days) | 28.9K | ★ 5.1M |
| Earning Date | 10-23-2025 | 11-10-2025 |
| Dividend Yield | ★ 10.53% | N/A |
| EPS Growth | ★ 15.49 | N/A |
| EPS | ★ 1.49 | N/A |
| Revenue | ★ $775,128,445.00 | N/A |
| Revenue This Year | $3.50 | N/A |
| Revenue Next Year | $5.30 | N/A |
| P/E Ratio | $9.48 | ★ N/A |
| Revenue Growth | ★ 3.60 | N/A |
| 52 Week Low | $7.00 | $1.87 |
| 52 Week High | $15.00 | $48.26 |
Technical Indicators
Market Signals| Indicator | BWMX | TERN |
|---|---|---|
| Relative Strength Index (RSI) | 49.02 | 79.72 |
| Support Level | $13.47 | $25.67 |
| Resistance Level | $14.50 | $48.26 |
| Average True Range (ATR) | 0.43 | 3.43 |
| MACD | -0.06 | 1.45 |
| Stochastic Oscillator | 42.86 | 83.71 |
Price Performance
Historical ComparisonAbout BWMX Betterware de Mexico S.A.P.I. de C.V.
Betterware de Mexico SAPI de CV is a direct-to-consumer selling company. The company operates through two business segments: the home organization products (Betterware segment or BWM segment) and the beauty and personal care products (B and PC) (JAFRA segment). The Betterware's segment is divided in seven categories of the home organization: Kitchen and food preservation, Home solutions, Bedroom, Bathroom, Laundry & Cleaning, Tech & mobility and wellness. The JAFRA's segment is divided into four categories beauty and personal care: fragrance, color (cosmetics), skin care and toiletries. The company generates a majority of its revenue from the Beauty and personal care (B&PC) (JAFRA segment). Geographically, key revenue for the company is derived from Mexico.
About TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.